Dr. Sabine Hazan: Ivermectin has a role potentially in cancer

"I submitted hypothesis on ivermectin increasing the Bifidobacteria and it was accepted by the peer review...it was an interesting hypothesis because we're seeing ivermectin has a role potentially in cancer, so maybe increasing the Bifidobacteria is how we're doing it.
Because it got so much attention, because it really lit up ivermectin, which they don't want to do.
Hydroxychloroquine and ivermectin are out of patents. So because they're out of patents you cannot make any money on these drugs. The most you can sell them for is like $300. Pharmaceutical companies are no longer interested in $300 drugs. They're interested in orphan drugs where they can get name your price for a drug...